Menarini Group chooses Enterprise Quality Management Solution to manage quality and maintain regulatory compliance HOLMDEL, N.J., May 11 /PRNewswire/ -- Sparta Systems, Inc., the maker of TrackWise(R) software and the market leader in enterprise quality and compliance management, today announced that Menarini Group, the world's leading Italian pharmaceutical group, has selected its TrackWise Enterprise Quality Management System (EQMS) to simplify quality processes throughout distributed manufacturing sites.

PALO ALTO, Calif., Sept. 12 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. announced today that it has entered into an agreement granting exclusive rights to Ranexa(R) (ranolazine prolonged release tablets) in Europe and other countries to the Menarini Group.

Oscient Pharmaceuticals Corporation's (Nasdaq: OSCI) commercialization partner for FACTIVE® (gemifloxacin mesylate) tablets, Menarini Group, a leading European pharmaceutical company based in Italy, has submitted a regulatory filing seeking approval of FACTIVE in Europe.

Goodwin Biotechnology and Menarini Group say they have completed the manufacture of monoclonal antibody abagovomab, the active principle of the Menarini ovarian cancer vaccine, to be used in phase III clinical studies around the world.

Goodwin Biotechnology, Inc. (GBI), of Plantation, Florida and Menarini Group, of Florence, Italy, have just announced the successful completion of a strategic co-operation for the manufacturing of the monoclonal antibody Abagovomab.